Galicaftor (ABBV-2222, GLPG-2222) is a potent and orally active cystic fibrosis transmembrane conductance regulator (CFTR) corrector that enhances CFTR protein folding and trafficking, Galicaftor is widely used in cystic fibrosis research to study CFTR rescue mechanisms, epithelial ion transport, and therapeutic correction of underlying molecular defects.
Molekulargewicht:
559.46
Reinheit:
98.84%
CAS Nummer:
[1918143-53-9]
Formel:
C28H21F4NO7
Target-Kategorie:
CFTR
T22252
T22252
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten